Sun Pharma and LIB Therapeutics announce global licensing agreement for Lerodalcibep
Read More
Sun Pharma Launches CTaro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
Read More
Sun Pharma reports Q1FY27 results
Read More
Sun Pharma receives approval to manufacture and market semaglutide in Brazil
Read More
Recent Comments